Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Non-Current Assets (2023 - 2025)

Cannabis Bioscience International Holdings' Non-Current Assets history spans 3 years, with the latest figure at $2795.0 for Q2 2025.

  • For Q2 2025, Non-Current Assets fell 92.16% year-over-year to $2795.0; the TTM value through Nov 2025 reached $13895.0, down 91.21%, while the annual FY2025 figure was $2795.0, 92.16% down from the prior year.
  • Non-Current Assets for Q2 2025 was $2795.0 at Cannabis Bioscience International Holdings, down from $11100.0 in the prior quarter.
  • Across five years, Non-Current Assets topped out at $82103.0 in Q4 2023 and bottomed at $2795.0 in Q2 2025.
  • The 3-year median for Non-Current Assets is $25728.5 (2023), against an average of $34751.6.
  • The largest annual shift saw Non-Current Assets skyrocketed 49.12% in 2024 before it tumbled 92.16% in 2025.
  • A 3-year view of Non-Current Assets shows it stood at $82103.0 in 2023, then crashed by 76.44% to $19347.0 in 2024, then plummeted by 85.55% to $2795.0 in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Non-Current Assets are $2795.0 (Q2 2025), $11100.0 (Q1 2025), and $19347.0 (Q4 2024).